Johnson And Johnson May Go Bankrupt With Lawsuits

Ad

ATLANTA, Georgia –

Johnson and Johnson is expected to go bankrupt once they are forced to settle the multiple class action suits have been brought against them. The company is accused of continuing to sell baby powder even after finding out talc causes cancer.

While talcum powder is widely used to help keep skin dry and prevent rashes, when used on the genitals or buttocks, talc particles can travel up the vagina or rectum and remain trapped for years. These particles can cause inflammation and lead to the growth of prostate or ovarian cancer cells.

Families are urged to stop using baby powder now and lawyer up, as their child has a ten percent change of developing prostate or ovarian cancer.

“Prostate and ovarian cancer would not be nearly as prevalent if it wasn’t put on nearly every baby’s bottom for the last fifty years,” says Gabriel Evans, an attorney representing the victims. “They knew it was killing people and did nothing about it. It’s just another instance of the big-baby industry caring more and bout profit than human lives.”

Johnson & Johnson Company Group Chairman, Alex Gorsky declined to comment on the lawsuits, but is rumored to have stopped powdering his balls.

Johnson & Johnson Announce New Tylenol With THC To Hit Market In Select Cities

tylenol

BENTONVILLE, Arkansas – 

Johnson & Johnson, the makers behind Tylenol pain reliever, announced today their intentions to begin selling their name-brand product with a THC additive. The company says that along with helping in pain relief, the THC also creates a “mild euphoric effect,” which can help patients in chronic pain.

Learn more about RevenueStripe...

“We’ve been studying the effects of marijuana, and its active ingredient, THC, for many years,” said Johnson & Johnson spokesman Hal Williams. “When combined with acetaminophen, the active ingredient of Tylenol, THC will work wonders in helping patients in long-term, chronic pain, to get some relief.”

Williams says that the company will only be marketing the product in places where medical or recreational marijuana has been made legal, but that they hope that, within a few years, they will be able to sell it openly, over-the-counter, everywhere in the United States.

“America has made leaps and bounds in legalizing marijuana and THC, specifically, but we’re not all the way there yet,” said Williams. “Johnson & Johnson definitely supports the efforts of groups looking to legalize, and we openly support the idea that this plant can be used as a medicine to treat many diseases.”

Johnson & Johnson Plans To Raise Price of Tylenol To $500 Per Pill

tylenol

DELUTH, Mississippi – 

After hedge-fund magnate Martin Shkreli announced that he would be raising the prices of Daraprim, a drug used to fight AIDS, from $13.50 to $750 per pill, several other companies decided to follow suit by drastically raising prices, including Johnson & Johnson, the trademark owners for the drug Tylenol.

“Frankly, a lot more people get headaches than have AIDS in this country,” said Johnson & Johnson spokesman Larry Myers. “If [Shkreli] is going to raise his prices on such a niche drug, and people will still have to buy it, then Tylenol is in an even better position to raise prices, as many, many more people use Tylenol on a regular basis than would ever use Daraprim.”

Myers says that the average cost of an individual Tylenol pill previously was about 17 cents, or about $8.99 for a bottle of 50 Tylenol pills. Tylenol PM, which is their number-one selling version of Tylenol, sold for about 27 cents previously, or about $13.99 for a bottle of 50.

“Tylenol PM, which many people in North America rely on to sleep easily at night, and wake up pain-free, will also be dramatically increased as well,” said Myers. “We expect to fetch around $800 per pill for the PM version of our flagship drug.”

Myers says that the price increase will not happen overnight, but that consumers should expect to see prices rising slowly over the next several months.

“If Shkreli can do it with Daraprim, then we can do it, too,” said Myers. “I sincerely hope that other drug companies realize that they should not be giving away their product so cheaply, and follow suit by bending customers over, and painfully raping them hard, right in their wallets. If only that monetary rape was a pain they needed Tylenol to get rid of, too.”

Design & Developed By Open Source Technologies.